HTGM

HTG Molecular Diagnostics, Inc. (HTGM) | Rumor.io

HTG Molecular Diagnostics

HTGM

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about HTGM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Jun 7

HTG Molecular Diagnostics, Inc. (HTGM) has filed for bankruptcy.
There is no market-relevant information provided about HTGM.
Some posts speculate about HTGM's potential price movement, but provide no concrete basis for these claims.

Generated by AI

Sentiment

Of the messages about HTGM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% 0
Bearish	—	—	—	0% 0

Bullish· Apr 18

$HTGM has seen significant price increases, with a 26.13% gain in a single day, indicating strong investor interest and potential for further growth.
The company has announced key first-quarter milestone achievements for drug discovery, which may have contributed to the stock's upward momentum and increased investor confidence.
$HTGM has demonstrated strong technical indicators, including a gap fill and a momentum indicator that has ascended above the 0 level, suggesting a potential continuation of the stock's upward trend.

Bearish· Dec 21

The company's share price has been significantly affected by a reverse stock split, with a one-for-twelve reverse split announced, followed by a 10.58% drop in price.
The company has been involved in a public offering, with a $10M securities offering priced at $7.75 per share, which led to a decline in the stock price.
The company's value is expected to plummet quickly and dramatically, with bleak expectations for the future, according to the company's engine assessment.

Generated by AI

Topics

Of the messages about HTGM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Earnings· May 10

$HTGM down 12.66% after hours to $3.45 due to lack of volume.
Downside not necessarily a bad sign, as EPS was better than expected.
No bad news in earnings report.

Announcements· Jun 6

HTG Molecular Diagnostics, Inc. (HTGM) filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code.
HTGM is down -47.55% after hours and -43.38% in the pre-market.
HTG Molecular Diagnostics, Inc. has experienced significant price drops, with no other relevant information provided in the posts.

Technical Analysis· Jan 13

$HTGM has been trading in a bull flag, with a possible breakout to $7 or higher after breaking VWAP.
The stock has shown a strong squeeze, with a 45.1% run, and has crossed above its 1-month SMA20, indicating a potential uptrend.
The RSI has moved over 70, indicating overbought conditions, and the stock is at a key level, with a possible test of VWAP at $7.

Generated by AI

Community

Of the messages about HTGM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	20.83%
Newcomers	—	—	100%	79.17%

Regulars· Jun 6

HTG Molecular Diagnostics, Inc. has filed for Chapter 11 bankruptcy protection after failing to meet a deadline to repay a loan.
The company's stock price has plummeted by 34.5% in pre-market trading following the bankruptcy filing.
HTG Molecular Diagnostics, Inc.'s Chapter 11 filing will likely result in the company undergoing a restructuring process.

Newcomers· Jun 6

Newcomers are focusing on $HTGM's significant drop in price, with a 47% decline to $0.9 after the company filed for bankruptcy.
The small float and market cap of $HTGM are being highlighted as a reason for potential volatility in the stock.
There is a warning that $HTGM may run within the next few days, possibly due to the lack of volume.

Generated by AI

News

Vaso Adds Financial Expert Shaun McMeans to Board

Detailed price information for Vaso Corp (VASO) from The Globe and Mail including charting and trades.

2mo agoThe Globe and Mail

Vaso appoints Shaun McMeans to board of directors

2mo agoInvesting.com

Also Discussed

Investors talking about HTGM also mention

#	Name	Attention
1	BIOC - Biocept, Inc.	——
2	Destination XL Group Inc.DXLG	0%new
3	Foresight Autonomous Holdings Ltd. ADRFRSX	0%+0
4	Pulmatrix Inc.PULM	0%0
5	Crescent Biopharma Inc.CBIO	0%0
6	NOVN - Novan, Inc.	——
7	TTNP - Titan Pharmaceuticals, Inc.	——
8	XSPA - XpresSpa Group, Inc.	——
9	Remark Holdings Inc.MARK	0%0
10	Vislink Technologies Inc.VISL	0%0